BioMarin Pharmaceuticals BMRN Rest of world — Total long-lived assets

Similar metrics at other companies

RMDRest of the World — Long-Lived Assets

$100.68M0.0%

DXCMOther countries — Total long-lived assets

$108M-10.2%

RBRKRest of world — Long-Lived Assets

$5.14M-16.9%

ARest Of World — Long-Lived Assets

$532M+0.6%

ILMNOther Countries — Total long-lived assets, net

$69M-14.8%

TDYAll other countries — Total long-lived assets

$53.7M+15.7%

Questions, answered.

What is BioMarin Pharmaceuticals's rest of world — total long-lived assets?

BioMarin Pharmaceuticals (BMRN) reported rest of world — total long-lived assets of $20.84M in Q4 2025.

How has BioMarin Pharmaceuticals's rest of world — total long-lived assets changed year-over-year?

BioMarin Pharmaceuticals's rest of world — total long-lived assets increased by 53.2% year-over-year, from $13.6M to $20.84M.

What does rest of world — total long-lived assets mean?

The total value of long-term assets, such as property and equipment, located in international regions outside the company's primary markets.

How do you interpret rest of world — total long-lived assets?

An increase suggests capital expansion or investment in infrastructure within these regions, while a decrease may indicate asset divestiture or depreciation exceeding new investment.

How does rest of world — total long-lived assets compare across companies?

Peers in the pharmaceutical industry typically report this as 'Long-lived assets by geography,' allowing for comparison of international manufacturing and distribution infrastructure intensity.